For instance, Hao et al. (2021) showed that 25–100 mg/kg baicalin effectively inhibited pulmonary inflammation, apoptosis, and alveolar injury in COPD models by activating HSP72 and blocking JNK pathway activation without causing weight loss or liver and kidney toxicity. This evidence concerns the gene MAPK8 and chronic obstructive pulmonary disease.